# Ian E. Smith

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/ian-e-smith/

## Facts

| Field | Value |
| --- | --- |
| Citations | 31,965 |
| Field | Breast Cancer Treatment Studies |
| h-index | 83 |
| i10-index | 264 |
| Last Known Institution | Papworth Hospital |
| OpenAlex ID | https://openalex.org/A5103543463 |
| Works | 544 |

## Researcher papers

- [Triple-Negative Breast Cancer](https://scholariq.org/papers/triple-negative-breast-cancer/)
- [Catalytic in vivo protein knockdown by small-molecule PROTACs](https://scholariq.org/papers/catalytic-in-vivo-protein-knockdown-by-small-molecule-protacs/)
- [Mutation tracking in circulating tumor DNA predicts relapse in early breast cancer](https://scholariq.org/papers/mutation-tracking-in-circulating-tumor-dna-predicts-relapse-in-early-breast/)
- [Carboplatin in BRCA1/2-mutated and triple-negative breast cancer BRCAness subgroups: the TNT Trial](https://scholariq.org/papers/carboplatin-in-brca1-2-mutated-and-triple-negative-breast-cancer-brcaness/)
- [Aromatase Inhibitors in Breast Cancer](https://scholariq.org/papers/aromatase-inhibitors-in-breast-cancer/)
- [Proliferation Marker Ki-67 in Early Breast Cancer](https://scholariq.org/papers/proliferation-marker-ki-67-in-early-breast-cancer/)
- [Neoadjuvant Treatment of Postmenopausal Breast Cancer With Anastrozole, Tamoxifen, or Both in Combination: The Immediate Preoperative Anastrozole, Tamoxifen, or Combined With Tamoxifen (IMPACT) Multicenter Double-Blind Randomized Trial](https://scholariq.org/papers/neoadjuvant-treatment-of-postmenopausal-breast-cancer-with-anastrozole-tamoxifen/)
- [Assessment of Ki67 in Breast Cancer: Updated Recommendations From the International Ki67 in Breast Cancer Working Group](https://scholariq.org/papers/assessment-of-ki67-in-breast-cancer-updated-recommendations-from-the/)
- [Prognostic Value of Ki67 Expression After Short-Term Presurgical Endocrine Therapy for Primary Breast Cancer](https://scholariq.org/papers/prognostic-value-of-ki67-expression-after-short-term-presurgical-endocrine/)
- [Analysis of <i>ESR1</i> mutation in circulating tumor DNA demonstrates evolution during therapy for metastatic breast cancer](https://scholariq.org/papers/analysis-of-i-esr1-i-mutation-in-circulating-tumor-dna-demonstrates-evolution/)
- [Idiopathic Hypersomnia: A Study of 77 Cases](https://scholariq.org/papers/idiopathic-hypersomnia-a-study-of-77-cases/)

## Researcher topics

- [Breast Cancer Treatment Studies](https://scholariq.org/topics/breast-cancer-treatment-studies/)
- [Estrogen and related hormone effects](https://scholariq.org/topics/estrogen-and-related-hormone-effects/)
- [HER2/EGFR in Cancer Research](https://scholariq.org/topics/her2-egfr-in-cancer-research/)
- [Cancer Treatment and Pharmacology](https://scholariq.org/topics/cancer-treatment-and-pharmacology/)
- [Advanced Breast Cancer Therapies](https://scholariq.org/topics/advanced-breast-cancer-therapies/)

## Researcher university

- [Papworth Hospital](https://scholariq.org/institutions/papworth-hospital/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.